ALKS vs MMC · P/E 14, rev $1.56B vs P/E 22, rev $24.46B
Alkermes Plc (ALKS) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the ALKS and MMC stock pages for the full models.
Not investment advice.